The PTT (Partial Thromboplastin Time) or aPTT (Activated Partial Thromboplastin Time) test is a laboratory test that measures the time it takes for blood to clot. It helps assess the functioning of the body's blood clotting mechanisms and can detect any potential bleeding disorders or monitor the effectiveness of anticoagulant medications. By measuring the time it takes for the blood to clot, healthcare professionals can diagnose and manage various conditions, including hemorrhage risk, liver disease, and clotting factor deficiencies.
To continue booking, you need to select at least 1 test
* Results are available same day by 9 p.m. 99% of the time. On rare occasions, it may take up to 3 business days to receive results.
The partial thromboplastin time (PTT), also referred to as activated partial thromboplastin time (aPTT), serves as a preliminary test to assess an individual's capacity to effectively develop blood clots. It quantifies the duration, in seconds, needed for a blood clot to form within a blood sample following the addition of specific substances (reagents). PTT evaluates both the quantity and functionality of specific blood proteins known as coagulation or clotting factors, which play a crucial role in the process of blood clot formation.
The primary purpose of PTT is to explore instances of unexplained bleeding or clotting. It is often requested in conjunction with a prothrombin time (PT/INR) to assess the body's clot formation process, which aids in halting bleeding. Typically, these tests serve as initial steps in the examination of disorders related to excessive bleeding or clotting.
The PTT may be included in a panel of tests, including the PT, when you exhibit:
Unexplained bleeding or susceptibility to bruising
The presence of a blood clot in a vein or artery
An acute ailment like disseminated intravascular coagulation (DIC), which can lead to both bleeding and clotting due to rapid depletion of coagulation factors
A chronic condition such as liver disease that may impact blood clotting.
No specific preparations are required; however, it is advisable to abstain from consuming a high-fat meal prior to the blood draw, as it may potentially affect the test results.
The partial thromboplastin time (PTT), or activated partial thromboplastin time (aPTT), serves as a preliminary assessment to determine an individual's competence in forming blood clots effectively. This test gauges the time, measured in seconds, required for a blood clot to develop within a blood sample following the introduction of specific substances (reagents). PTT evaluates the quantity and functionality of specific blood proteins known as coagulation or clotting factors, which play a vital role in the blood clot formation process.
PTT is primarily employed to explore instances of unexplained bleeding or clotting. It is often prescribed alongside a prothrombin time (PT/INR) test to scrutinize the body's clot formation process, which aids in arresting bleeding. These tests typically serve as the initial steps in the examination of disorders associated with excessive bleeding or clotting.
By assessing the outcomes of both tests in conjunction, a healthcare provider can glean insights into the potential bleeding or clotting disorder at hand. While the PTT and PT are not diagnostic in themselves, they commonly offer insights into whether additional tests may be warranted.
A PTT test may be requested in the following scenarios:
The PTT test may be requested alongside other tests, including a PT, when you exhibit:
PTT results are typically reported in seconds.
A PTT result that falls within a laboratorys reference range usually indicates normal clotting function. However, it's important to note that even with a normal PTT result, mild to moderate deficiencies of a single coagulation factor may be present. Prolongation of the PTT may not become evident until the factor levels have decreased to 30% to 40% of normal. Conversely, the presence of lupus anticoagulant (LA) may not significantly extend the PTT result. If there is suspicion of lupus anticoagulant (LA), a more sensitive LA-sensitive PTT or a dilute Russell viper venom time (DRVVT) can be employed for testing. (See below for additional information on LA-sensitive PTT.)
A prolonged PTT implies that the process of blood clotting is taking longer than usual to occur and may be attributed to various underlying causes.
A prolonged PTT indicates that the blood is taking longer than normal to clot and may have various underlying causes, including:
- Liver disease: Most coagulation factors are produced by the liver, so liver disease can cause prolonged PT and PTT. However, PT is more likely to be prolonged than PTT.
- Vitamin K deficiency: Vitamin K is essential for the formation of several clotting factors. Vitamin K deficiencies can result from a poor diet, malabsorption disorders, or prolonged use of specific antibiotics, for instance. PT is more likely to be prolonged than PTT.
- von Willebrand disease (vWD): This is the most common inherited bleeding disorder and affects platelet function due to decreased von Willebrand factor. In most cases of vWD, PTT is normal but can be prolonged in severe cases.
- Hemophilia A and hemophilia B (Christmas disease): These are other inherited bleeding disorders that result from a decrease in factors VIII and IX, respectively.
- Deficiencies of other coagulation factors, such as factors XII and XI: Deficiency in factor XI can cause abnormal bleeding, but factor XII deficiency is not associated with bleeding risk in the body.
- Heparin: Heparin is an anticoagulant and can prolong PTT, either as a contaminant of the sample or as part of anticoagulation therapy. For anticoagulant therapy, the target PTT is often about 1.5 to 2.5 times longer than a person's pretreatment level. PTT is still used to monitor standard heparin therapy.
- Warfarin (Coumadin) anticoagulation therapy: PTT is not used to monitor warfarin therapy, but high doses of warfarin can prolong PTT. Typically, the prothrombin time/international normalized ratio (PT/INR) is used to monitor warfarin therapy.
- Other anticoagulants: Anticoagulation therapy with direct thrombin inhibitors (e.g., argatroban, dabigatran) or direct factor Xa inhibitors (e.g., rivaroxaban, apixaban).
- Prolonged PTT levels may also be observed in certain types of leukemia, excessive bleeding in pregnant women before or after childbirth, or recurrent miscarriages.
The interpretation of PTT results is often done in conjunction with PT results to determine the underlying condition that may be present.
The LA-sensitive PTT (LA-PTT or PTT-LA) is a specialized version of the partial thromboplastin time (PTT) test, specifically designed to detect the presence of lupus anticoagulant (LA). Lupus anticoagulant is an antibody associated with abnormal blood clotting and recurrent miscarriages. The LA-PTT employs a low phospholipid reagent that is finely tuned to detect lupus anticoagulants, making it more sensitive in identifying their presence. This test operates on the principle that lupus anticoagulants interact with the phospholipids used in the PTT test, leading to an abnormally prolonged clotting time.
Additional tests that may be conducted alongside a PTT or as a follow-up to abnormal PTT results include:
In cases where an initial PTT result is prolonged, a second PTT test is typically conducted by mixing the individual's plasma with pooled normal plasma, which comprises plasma from several healthy donors. If the PTT time returns to normal ("corrects"), it suggests a deficiency of one or more coagulation factors in the individual's plasma. If the time remains prolonged, the issue may be attributed to the presence of an abnormal factor-specific inhibitor (autoantibody) or a nonspecific inhibitor, such as lupus anticoagulant.
Other related tests may include:
The PTT is not influenced by lifestyle changes (unless a vitamin K deficiency is the underlying cause). It serves as an indicator of your clotting system's function and integrity. If your PTT is prolonged due to acquired factor deficiencies, addressing the root cause of the deficiency can help normalize the results. In cases where the prolongation is linked to a temporary or acute condition, the PTT should naturally return to normal as the acute condition resolves. Inherited coagulation abnormalities or deficiencies require close monitoring and may involve frequent replacement infusions of the deficient clotting factor as part of treatment.
Best Prices
Our fully automated private laboratory with cutting edge technology is able to reduce costs while increasing consistency and reproducibility of results.
Faster Service
We have designed our clinics and testing processes to be efficient, reducing wait times and time for results.
More Precise Information
Our test reports provide more precise information on test results, making it easier to monitor any changes in your health over time.
Free Parking
All our clinics provide free and available parking, helping you to save even more money and time.
Customer Support
Our online booking portal and helpful testing center staff help to make diagnostic testing more convenient and compassionate.
IMPLEMENT AFFORDABLE ACTION
Companies and institutions can deploy large-scale diagnostic testing at a fraction of the cost of testing centers with Lilium’s automated laboratory testing platforms and reporting.
STAY AHEAD OF OUTBREAKS
Lilium's pioneering testing system secures workplaces and communities against expensive shutdowns by keeping businesses and organizations ahead of outbreaks.
REDUCE RISKS
Robotic analysis improves accuracy of results by drastically reducing the risk of false negatives and positives.
To make an appointment, please choose from one of our clinics below:
Monday - Saturday
7:00 - 10:00
12:00 - 15:00
We provide FREE parking at our convenient locations
Our downtown Montreal location is located on the mezzanine level of the Alexis Nihon Center with 1 hour free indoor parking. Atwater metro station has a direct inside connection to Alexis Nihon.
If you’re driving to our Laval location, we are right off Autoroute 15 and have plenty of free parking.
If you arrive by public metro, there is a walkway to our lab from Metro Montmorency (a 20 minute walk).
What our customers say about us
ASK US ANYTHING
We're here to help make sense of it all.
Or send us an e-mail